{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T05:16:04Z","timestamp":1791954964554,"version":"4.3.4"},"reference-count":176,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"DOI":"10.1186\/s10194-026-02358-3","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T01:54:51Z","timestamp":1776131691000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Breaking the medication overuse headache cycle: from nociplastic pain mechanisms to patient-centered interventions \u2014 the Junior Editorial Board vision"],"prefix":"10.1186","volume":"27","author":[{"given":"Roberta","family":"Messina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Castaldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woo-Seok","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Labastida-Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie Merve","family":"Yener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnese","family":"Onofri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eloisa","family":"Rubio-Beltran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Sebastianelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doga","family":"Vuralli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Wells-Gatnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Martelletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,14]]},"reference":[{"issue":"1","key":"2358_CR1","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s10194-018-0865-z","volume":"19","author":"TJ Schwedt","year":"2018","unstructured":"Schwedt TJ, Alam A, Reed ML, Fanning KM, Munjal S, Buse DC et al (2018) Factors associated with acute medication overuse in people with migraine: results from the 2017 migraine in America symptoms and treatment (MAST) study. J Headache Pain 19(1):38","journal-title":"J Headache Pain"},{"issue":"1","key":"2358_CR2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41572-022-00415-0","volume":"9","author":"S Ashina","year":"2023","unstructured":"Ashina S, Terwindt GM, Steiner TJ, Lee MJ, Porreca F, Tassorelli C et al (2023) Medication overuse headache. Nat Rev Dis Primers 9(1):5","journal-title":"Nat Rev Dis Primers"},{"issue":"12","key":"2358_CR3","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/S1474-4422(25)00402-8","volume":"24","author":"GBDH Collaborators","year":"2025","unstructured":"Collaborators GBDH (2025) Global, regional, and national burden of headache disorders, 1990\u20132023: a systematic analysis for the Global Burden of Disease Study 2023. Lancet Neurol 24(12):1005\u20131015","journal-title":"Lancet Neurol"},{"issue":"9","key":"2358_CR4","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/S1474-4422(19)30146-2","volume":"18","author":"HC Diener","year":"2019","unstructured":"Diener HC, Dodick D, Evers S, Holle D, Jensen RH, Lipton RB et al (2019) Pathophysiology, prevention, and treatment of medication overuse headache. Lancet Neurol 18(9):891\u2013902","journal-title":"Lancet Neurol"},{"issue":"2","key":"2358_CR5","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1007\/s11916-008-0023-4","volume":"12","author":"K Paemeleire","year":"2008","unstructured":"Paemeleire K, Evers S, Goadsby PJ (2008) Medication-overuse headache in patients with cluster headache. Curr Pain Headache Rep 12(2):122\u2013127","journal-title":"Curr Pain Headache Rep"},{"issue":"1","key":"2358_CR6","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s10194-024-01755-w","volume":"25","author":"H Gosalia","year":"2024","unstructured":"Gosalia H, Moreno-Ajona D, Goadsby PJ (2024) Medication-overuse headache: a narrative review. J Headache Pain 25(1):89","journal-title":"J Headache Pain"},{"issue":"7","key":"2358_CR7","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1097\/j.pain.0000000000000507","volume":"157","author":"E Kosek","year":"2016","unstructured":"Kosek E, Cohen M, Baron R, Gebhart GF, Mico JA, Rice ASC et al (2016) Do we need a third mechanistic descriptor for chronic pain states? Pain 157(7):1382\u20131386","journal-title":"Pain"},{"issue":"10289","key":"2358_CR8","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1016\/S0140-6736(21)00392-5","volume":"397","author":"MA Fitzcharles","year":"2021","unstructured":"Fitzcharles MA, Cohen SP, Clauw DJ, Littlejohn G, Usui C, Hauser W (2021) Nociplastic pain: towards an understanding of prevalent pain conditions. Lancet 397(10289):2098\u20132110","journal-title":"Lancet"},{"issue":"4","key":"2358_CR9","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1002\/ana.26583","volume":"93","author":"R Messina","year":"2023","unstructured":"Messina R, Sudre CH, Wei DY, Filippi M, Ourselin S, Goadsby PJ (2023) Biomarkers of Migraine and Cluster Headache: Differences and Similarities. Ann Neurol 93(4):729\u2013742","journal-title":"Ann Neurol"},{"issue":"4","key":"2358_CR10","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/j.1468-2982.2008.01754.x","volume":"29","author":"M de Tommaso","year":"2009","unstructured":"de Tommaso M, Sardaro M, Serpino C, Costantini F, Vecchio E, Prudenzano MP et al (2009) Fibromyalgia comorbidity in primary headaches. Cephalalgia 29(4):453\u2013464","journal-title":"Cephalalgia"},{"issue":"3","key":"2358_CR11","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1586\/ern.11.190","volume":"12","author":"M de Tommaso","year":"2012","unstructured":"de Tommaso M (2012) Prevalence, clinical features and potential therapies for fibromyalgia in primary headaches. Expert Rev Neurother 12(3):287\u2013295 quiz 96","journal-title":"Expert Rev Neurother"},{"key":"2358_CR12","unstructured":"Terminology IAftSoPII (2017) [Available from: https:\/\/www.iasp-pain.org\/terminology?navItemNumber=576"},{"issue":"3","key":"2358_CR13","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1002\/ana.21897","volume":"67","author":"M De Felice","year":"2010","unstructured":"De Felice M, Ossipov MH, Wang R, Lai J, Chichorro J, Meng I et al (2010) Triptan-induced latent sensitization: a possible basis for medication overuse headache. Ann Neurol 67(3):325\u2013337","journal-title":"Ann Neurol"},{"issue":"10","key":"2358_CR14","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1097\/j.pain.0000000000001291","volume":"159","author":"D Buonvicino","year":"2018","unstructured":"Buonvicino D, Urru M, Muzzi M, Ranieri G, Luceri C, Oteri C et al (2018) Trigeminal ganglion transcriptome analysis in 2 rat models of medication-overuse headache reveals coherent and widespread induction of pronociceptive gene expression patterns. Pain 159(10):1980\u20131988","journal-title":"Pain"},{"issue":"11","key":"2358_CR15","doi-asserted-by":"publisher","first-page":"108153","DOI":"10.1016\/j.isci.2023.108153","volume":"26","author":"Z Gong","year":"2023","unstructured":"Gong Z, Yang C, Dai W, Miao S, Liu Y, Jiao Z et al (2023) Annexin A1 exerts analgesic effect in a mouse model of medication overuse headache. iScience 26(11):108153","journal-title":"iScience"},{"issue":"1","key":"2358_CR16","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s10194-025-02066-4","volume":"26","author":"Z Ma","year":"2025","unstructured":"Ma Z, Li C, Bai W, Xie W, Zhang M, Xiao H et al (2025) Induction of more severe central sensitization in a medication overuse headache model mice through active ingestion of rizatriptan. J Headache Pain 26(1):123","journal-title":"J Headache Pain"},{"issue":"1","key":"2358_CR17","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s10194-022-01405-z","volume":"23","author":"D Vuralli","year":"2022","unstructured":"Vuralli D, Arslan B, Topa E, de Morais AL, Gulbahar O, Ayata C et al (2022) Migraine susceptibility is modulated by food triggers and analgesic overuse via sulfotransferase inhibition. J Headache Pain 23(1):36","journal-title":"J Headache Pain"},{"issue":"8","key":"2358_CR18","first-page":"594","volume":"34","author":"AL Green","year":"2014","unstructured":"Green AL, Gu P, De Felice M, Dodick D, Ossipov MH, Porreca F (2014) Increased susceptibility to cortical spreading depression in an animal model of medication-overuse headache. Ceph: Int J Headache 34(8):594\u2013604","journal-title":"Ceph: Int J Headache"},{"issue":"9","key":"2358_CR19","first-page":"1101","volume":"30","author":"W Supornsilpchai","year":"2010","unstructured":"Supornsilpchai W, le Grand SM, Srikiatkhachorn A (2010) Cortical hyperexcitability and mechanism of medication-overuse headache. Ceph: Int J Headache 30(9):1101\u20131109","journal-title":"Ceph: Int J Headache"},{"issue":"1","key":"2358_CR20","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1152\/jn.00632.2015","volume":"115","author":"L Becerra","year":"2016","unstructured":"Becerra L, Bishop J, Barmettler G, Xie Y, Navratilova E, Porreca F et al (2016) Triptans disrupt brain networks and promote stress-induced CSD-like responses in cortical and subcortical areas. J Neurophysiol 115(1):208\u2013217","journal-title":"J Neurophysiol"},{"issue":"2","key":"2358_CR21","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/j.1526-4610.2009.01591.x","volume":"50","author":"W Supornsilpchai","year":"2010","unstructured":"Supornsilpchai W, le Grand SM, Srikiatkhachorn A (2010) Involvement of pro-nociceptive 5-HT2A receptor in the pathogenesis of medication-overuse headache. Headache 50(2):185\u2013197","journal-title":"Headache"},{"issue":"5","key":"2358_CR22","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1046\/j.1526-4610.2000.00052.x","volume":"40","author":"A Srikiatkhachorn","year":"2000","unstructured":"Srikiatkhachorn A, Tarasub N, Govitrapong P (2000) Effect of chronic analgesic exposure on the central serotonin system: a possible mechanism of analgesic abuse headache. Headache 40(5):343\u2013350","journal-title":"Headache"},{"issue":"9","key":"2358_CR23","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1111\/j.1468-2982.2006.01183.x","volume":"26","author":"I Ayzenberg","year":"2006","unstructured":"Ayzenberg I, Obermann M, Nyhuis P, Gastpar M, Limmroth V, Diener HC et al (2006) Central sensitization of the trigeminal and somatic nociceptive systems in medication overuse headache mainly involves cerebral supraspinal structures. Cephalalgia 26(9):1106\u20131114","journal-title":"Cephalalgia"},{"issue":"7","key":"2358_CR24","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1177\/0333102412475235","volume":"33","author":"SB Munksgaard","year":"2013","unstructured":"Munksgaard SB, Bendtsen L, Jensen RH (2013) Modulation of central sensitisation by detoxification in MOH: results of a 12-month detoxification study. Cephalalgia 33(7):444\u2013453","journal-title":"Cephalalgia"},{"issue":"3","key":"2358_CR25","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1111\/j.1468-2982.2009.01914.x","volume":"30","author":"A Perrotta","year":"2010","unstructured":"Perrotta A, Serrao M, Sandrini G, Burstein R, Sances G, Rossi P et al (2010) Sensitisation of spinal cord pain processing in medication overuse headache involves supraspinal pain control. Cephalalgia 30(3):272\u2013284","journal-title":"Cephalalgia"},{"issue":"5","key":"2358_CR26","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1111\/j.1526-4610.2012.02151.x","volume":"52","author":"D Ferraro","year":"2012","unstructured":"Ferraro D, Vollono C, Miliucci R, Virdis D, De Armas L, Pazzaglia C et al (2012) Habituation to pain in medication overuse headache: a CO2 laser-evoked potential study. Headache 52(5):792\u2013807","journal-title":"Headache"},{"key":"2358_CR27","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/1471-2377-10-126","volume":"10","author":"G Coppola","year":"2010","unstructured":"Coppola G, Curr\u00e0 A, Di Lorenzo C, Parisi V, Gorini M, Sava SL et al (2010) Abnormal cortical responses to somatosensory stimulation in medication-overuse headache. BMC Neurol 10:126","journal-title":"BMC Neurol"},{"issue":"10","key":"2358_CR28","doi-asserted-by":"publisher","first-page":"333102423120224","DOI":"10.1177\/03331024231202240","volume":"43","author":"G Sebastianelli","year":"2023","unstructured":"Sebastianelli G, Casillo F, Abagnale C, Renzo AD, Cioffi E, Parisi V et al (2023) Central sensitization mechanisms in chronic migraine with medication overuse headache: a study of thalamocortical activation and lateral cortical inhibition. Cephalalgia 43(10):3331024231202240","journal-title":"Cephalalgia"},{"key":"2358_CR29","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3390\/jcm13237491","volume":"13","author":"G Sebastianelli","year":"2024","unstructured":"Sebastianelli G, Casillo F, Abagnale C, Di Renzo A, Ziccardi L, Parisi V et al (2024) Neurophysiological Effects of Withdrawal from Acute Overused Medications in Chronic Migraine with Medication-Overuse Headache. J Clin Med 13:23","journal-title":"J Clin Med"},{"issue":"2","key":"2358_CR30","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1177\/0333102418784747","volume":"39","author":"F Cortese","year":"2019","unstructured":"Cortese F, Pierelli F, Pauri F, Di Lorenzo C, Lepre C, Malavolta G et al (2019) Short-term cortical synaptic depression\/potentiation mechanisms in chronic migraine patients with or without medication overuse. Cephalalgia 39(2):237\u2013244","journal-title":"Cephalalgia"},{"issue":"12","key":"2358_CR31","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1177\/0333102411415877","volume":"31","author":"A Curr\u00e0","year":"2011","unstructured":"Curr\u00e0 A, Coppola G, Gorini M, Porretta E, Bracaglia M, Di Lorenzo C et al (2011) Drug-induced changes in cortical inhibition in medication overuse headache. Cephalalgia 31(12):1282\u20131290","journal-title":"Cephalalgia"},{"key":"2358_CR32","doi-asserted-by":"crossref","unstructured":"Coppola G, Casillo F, Sebastianelli G, Abagnale C, Di Lorenzo C, Di Renzo A et al (2024) Decoding visual responses: insights into chronic migraine and medication overuse headache with electrophysiological analysis. J Clin Med 13(20)","DOI":"10.3390\/jcm13206070"},{"issue":"1","key":"2358_CR33","doi-asserted-by":"publisher","first-page":"e70171","DOI":"10.1002\/ejp.70171","volume":"30","author":"RF van Welie","year":"2026","unstructured":"van Welie RF, van Welie FC, Trouerbach-Kraan JP, Dahan A, van Velzen M, Terwindt GM (2026) Exploratory Pain Profiling With Quantitative Sensory Testing (QST) in Episodic and Chronic Migraine. Eur J Pain 30(1):e70171","journal-title":"Eur J Pain"},{"issue":"39","key":"2358_CR34","doi-asserted-by":"publisher","first-page":"15343","DOI":"10.1523\/JNEUROSCI.3804-12.2013","volume":"33","author":"F Riederer","year":"2013","unstructured":"Riederer F, Gantenbein AR, Marti M, Luechinger R, Kollias S, Sandor PS (2013) Decrease of gray matter volume in the midbrain is associated with treatment response in medication-overuse headache: possible influence of orbitofrontal cortex. J Neurosci 33(39):15343\u201315349","journal-title":"J Neurosci"},{"issue":"5","key":"2358_CR35","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1007\/s11682-022-00634-9","volume":"16","author":"W Chen","year":"2022","unstructured":"Chen W, Li H, Hou X, Jia X (2022) Gray matter alteration in medication overuse headache: a coordinates-based activation likelihood estimation meta-analysis. Brain Imaging Behav 16(5):2307\u20132319","journal-title":"Brain Imaging Behav"},{"issue":"3","key":"2358_CR36","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/WCO.0b013e328346af25","volume":"24","author":"M De Felice","year":"2011","unstructured":"De Felice M, Ossipov MH, Porreca F (2011) Persistent medication-induced neural adaptations, descending facilitation, and medication overuse headache. Curr Opin Neurol 24(3):193\u2013196","journal-title":"Curr Opin Neurol"},{"issue":"3 Suppl","key":"2358_CR37","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1016\/j.pain.2010.11.010","volume":"152","author":"VA Apkarian","year":"2011","unstructured":"Apkarian VA, Hashmi JA, Baliki MN (2011) Pain and the brain: specificity and plasticity of the brain in clinical chronic pain. Pain 152(3 Suppl):S49\u2013S64","journal-title":"Pain"},{"issue":"10","key":"2358_CR38","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1111\/j.1526-4610.2012.02276.x","volume":"52","author":"S Ferraro","year":"2012","unstructured":"Ferraro S, Grazzi L, Muffatti R, Nava S, Ghielmetti F, Bertolino N et al (2012) In medication-overuse headache, FMRI shows long-lasting dysfunction in midbrain areas. Headache 52(10):1520\u20131534","journal-title":"Headache"},{"issue":"Pt 2","key":"2358_CR39","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1093\/brain\/awh691","volume":"129","author":"A Fumal","year":"2006","unstructured":"Fumal A, Laureys S, Di Clemente L, Boly M, Bohotin V, Vandenheede M et al (2006) Orbitofrontal cortex involvement in chronic analgesic-overuse headache evolving from episodic migraine. Brain 129(Pt 2):543\u2013550","journal-title":"Brain"},{"issue":"8","key":"2358_CR40","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1177\/0333102416652625","volume":"37","author":"L Michels","year":"2017","unstructured":"Michels L, Christidi F, Steiger VR, Sandor PS, Gantenbein AR, Landmann G et al (2017) Pain modulation is affected differently in medication-overuse headache and chronic myofascial pain - A multimodal MRI study. Cephalalgia 37(8):764\u2013779","journal-title":"Cephalalgia"},{"issue":"2","key":"2358_CR41","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s00415-016-8349-z","volume":"264","author":"R Messina","year":"2017","unstructured":"Messina R, Rocca MA, Colombo B, Teggi R, Falini A, Comi G et al (2017) Structural brain abnormalities in patients with vestibular migraine. J Neurol 264(2):295\u2013303","journal-title":"J Neurol"},{"key":"2358_CR42","doi-asserted-by":"publisher","first-page":"1236069","DOI":"10.3389\/fnins.2023.1236069","volume":"17","author":"M Zhao","year":"2023","unstructured":"Zhao M, Hao Z, Li M, Xi H, Hu S, Wen J et al (2023) Functional changes of default mode network and structural alterations of gray matter in patients with irritable bowel syndrome: a meta-analysis of whole-brain studies. Front Neurosci 17:1236069","journal-title":"Front Neurosci"},{"issue":"7","key":"2358_CR43","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1002\/art.34412","volume":"64","author":"V Napadow","year":"2012","unstructured":"Napadow V, Kim J, Clauw DJ, Harris RE (2012) Decreased intrinsic brain connectivity is associated with reduced clinical pain in fibromyalgia. Arthritis Rheum 64(7):2398\u20132403","journal-title":"Arthritis Rheum"},{"issue":"8","key":"2358_CR44","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1177\/0333102413519514","volume":"34","author":"S Chanraud","year":"2014","unstructured":"Chanraud S, Di Scala G, Dilharreguy B, Schoenen J, Allard M, Radat F (2014) Brain functional connectivity and morphology changes in medication-overuse headache: Clue for dependence-related processes? Cephalalgia 34(8):605\u2013615","journal-title":"Cephalalgia"},{"issue":"3","key":"2358_CR45","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1111\/j.1526-4610.2008.01257.x","volume":"49","author":"S Cevoli","year":"2009","unstructured":"Cevoli S, Sancisi E, Grimaldi D, Pierangeli G, Zanigni S, Nicodemo M et al (2009) Family history for chronic headache and drug overuse as a risk factor for headache chronification. Headache 49(3):412\u2013418","journal-title":"Headache"},{"key":"2358_CR46","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1146\/annurev.pharmtox.010909.105826","volume":"50","author":"JY Khokhar","year":"2010","unstructured":"Khokhar JY, Ferguson CS, Zhu AZ, Tyndale RF (2010) Pharmacogenetics of drug dependence: role of gene variations in susceptibility and treatment. Annu Rev Pharmacol Toxicol 50:39\u201361","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"2","key":"2358_CR47","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.tips.2004.12.008","volume":"26","author":"P Calabresi","year":"2005","unstructured":"Calabresi P, Cupini LM (2005) Medication-overuse headache: similarities with drug addiction. Trends Pharmacol Sci 26(2):62\u201368","journal-title":"Trends Pharmacol Sci"},{"issue":"16","key":"2358_CR48","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1177\/0333102412461890","volume":"32","author":"C Di Lorenzo","year":"2012","unstructured":"Di Lorenzo C, Coppola G, Curra A, Grieco G, Santorelli FM, Lepre C et al (2012) Cortical response to somatosensory stimulation in medication overuse headache patients is influenced by angiotensin converting enzyme (ACE) I\/D genetic polymorphism. Cephalalgia 32(16):1189\u20131197","journal-title":"Cephalalgia"},{"issue":"5","key":"2358_CR49","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s10194-009-0136-0","volume":"10","author":"C Di Lorenzo","year":"2009","unstructured":"Di Lorenzo C, Di Lorenzo G, Sances G, Ghiotto N, Guaschino E, Grieco GS et al (2009) Drug consumption in medication overuse headache is influenced by brain-derived neurotrophic factor Val66Met polymorphism. J Headache Pain 10(5):349\u2013355","journal-title":"J Headache Pain"},{"issue":"7","key":"2358_CR50","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1111\/ene.12424","volume":"21","author":"S Cargnin","year":"2014","unstructured":"Cargnin S, Viana M, Ghiotto N, Bianchi M, Sances G, Tassorelli C et al (2014) Functional polymorphisms in COMT and SLC6A4 genes influence the prognosis of patients with medication overuse headache after withdrawal therapy. Eur J Neurol 21(7):989\u2013995","journal-title":"Eur J Neurol"},{"issue":"1","key":"2358_CR51","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/j.1468-1331.2011.03436.x","volume":"19","author":"S Terrazzino","year":"2012","unstructured":"Terrazzino S, Tassorelli C, Sances G, Allena M, Viana M, Monaco F et al (2012) Association of haplotype combination of serotonin transporter gene polymorphisms with monthly headache days in MOH patients. Eur J Neurol 19(1):69\u201375","journal-title":"Eur J Neurol"},{"issue":"Suppl 1","key":"2358_CR52","doi-asserted-by":"publisher","first-page":"A49","DOI":"10.1186\/1129-2377-16-S1-A49","volume":"16","author":"C Di Lorenzo","year":"2015","unstructured":"Di Lorenzo C, Coppola G, Grieco G, Santorelli FM, Pascale E, Pierelli F (2015) O041. GRIA3 (glutamate receptor, ionotropic, ampa 3) gene polymorphism influences cortical response to somatosensory stimulation in medication-overuse headache (MOH) patients. J Headache Pain 16(Suppl 1):A49","journal-title":"J Headache Pain"},{"key":"2358_CR53","doi-asserted-by":"publisher","first-page":"599517","DOI":"10.3389\/fneur.2020.599517","volume":"11","author":"C Di Lorenzo","year":"2020","unstructured":"Di Lorenzo C, Di Lorenzo G, Coppola G, Parisi V, Grieco GS, Santorelli FM et al (2020) Genetics Influences Drug Consumption in Medication Overuse Headache, Not in Migraine: Evidence From Wolframin His611Arg Polymorphism Analysis. Front Neurol 11:599517","journal-title":"Front Neurol"},{"key":"2358_CR54","doi-asserted-by":"crossref","unstructured":"Johnston KJA, Signer R, Huckins LM (2024) Chronic Overlapping Pain Conditions and Nociplastic Pain. medRxiv","DOI":"10.1101\/2023.06.27.23291959"},{"issue":"3","key":"2358_CR55","doi-asserted-by":"publisher","first-page":"333102422114748","DOI":"10.1177\/03331024221147482","volume":"43","author":"LN Carlsen","year":"2023","unstructured":"Carlsen LN, Hansen CS, Kogelman LJA, Werge TM, Ullum H, Bybjerg-Grauholm J et al (2023) DNA-methylation and immunological response in medication overuse headache. Cephalalgia 43(3):3331024221147482","journal-title":"Cephalalgia"},{"issue":"1","key":"2358_CR56","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s10194-023-01672-4","volume":"24","author":"HG Dagidir","year":"2023","unstructured":"Dagidir HG, Topa E, Vuralli D, Bolay H (2023) Medication overuse headache is associated with elevated lipopolysaccharide binding protein and pro-inflammatory molecules in the bloodstream. J Headache Pain 24(1):150","journal-title":"J Headache Pain"},{"issue":"1","key":"2358_CR57","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s10194-024-01891-3","volume":"25","author":"D Vuralli","year":"2024","unstructured":"Vuralli D, Ceren Akgor M, Dagidir HG, Onat P, Yalinay M, Sezerman U et al (2024) Microbiota alterations are related to migraine food triggers and inflammatory markers in chronic migraine patients with medication overuse headache. J Headache Pain 25(1):192","journal-title":"J Headache Pain"},{"issue":"1","key":"2358_CR58","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/s10194-024-01900-5","volume":"25","author":"S Ryu","year":"2024","unstructured":"Ryu S, Zhang J, Simoes R, Liu X, Guo Z, Feng L et al (2024) Regulatory T cells require peripheral CCL2-CCR2 signaling to facilitate the resolution of medication overuse headache-related behavioral sensitization. J Headache Pain 25(1):197","journal-title":"J Headache Pain"},{"issue":"1","key":"2358_CR59","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s12891-020-03201-9","volume":"21","author":"S Erdrich","year":"2020","unstructured":"Erdrich S, Hawrelak JA, Myers SP, Harnett JE (2020) Determining the association between fibromyalgia, the gut microbiome and its biomarkers: A systematic review. BMC Musculoskelet Disord 21(1):181","journal-title":"BMC Musculoskelet Disord"},{"issue":"1\u20133","key":"2358_CR60","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.pain.2005.09.034","volume":"119","author":"JL Fuh","year":"2005","unstructured":"Fuh JL, Wang SJ, Lu SR, Juang KD (2005) Does medication overuse headache represent a behavior of dependence? Pain 119(1\u20133):49\u201355","journal-title":"Pain"},{"issue":"1","key":"2358_CR61","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s10194-021-01224-8","volume":"22","author":"TT Takahashi","year":"2021","unstructured":"Takahashi TT, Ornello R, Quatrosi G, Torrente A, Albanese M, Vigneri S et al (2021) Medication overuse and drug addiction: a narrative review from addiction perspective. J Headache Pain 22(1):32","journal-title":"J Headache Pain"},{"issue":"1","key":"2358_CR62","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s11916-011-0240-0","volume":"16","author":"JL Fuh","year":"2012","unstructured":"Fuh JL, Wang SJ (2012) Dependent behavior in patients with medication-overuse headache. Curr Pain Headache Rep 16(1):73\u201379","journal-title":"Curr Pain Headache Rep"},{"issue":"1","key":"2358_CR63","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/1129-2377-14-59","volume":"14","author":"F Radat","year":"2013","unstructured":"Radat F, Chanraud S, Di Scala G, Dousset V, Allard M (2013) Psychological and neuropsychological correlates of dependence-related behaviour in medication overuse headaches: a one year follow-up study. J Headache Pain 14(1):59","journal-title":"J Headache Pain"},{"issue":"11","key":"2358_CR64","doi-asserted-by":"publisher","first-page":"5375","DOI":"10.1007\/s10072-024-07639-w","volume":"45","author":"E Cesur","year":"2024","unstructured":"Cesur E, Yavuz BG, Acar E, Ozdemir Z, Soyukibar TE, Aydinlar EI (2024) Somatic amplification and addiction profile as risk factors for medication overuse headache with chronic migraine. Neurol Sci 45(11):5375\u20135383","journal-title":"Neurol Sci"},{"issue":"12","key":"2358_CR65","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1590\/0004-282x20200071","volume":"78","author":"LM Santos","year":"2020","unstructured":"Santos LM, Silva A, Brasil ABR, Tolentino ACA, Norberto CA, Paula CB et al (2020) Impulsivity prevalence in migraine patients without and with medication overuse. Arq Neuropsiquiatr 78(12):778\u2013782","journal-title":"Arq Neuropsiquiatr"},{"issue":"4","key":"2358_CR66","first-page":"1","volume":"83","author":"R Simsekoglu","year":"2025","unstructured":"Simsekoglu R, Keskin N, Cankay T, Cakmak S, Tombul T (2025) Impulsiveness levels among patients with medication-overuse headache accompanying chronic migraine or tension-type headache. Arq Neuropsiquiatr 83(4):1\u20138","journal-title":"Arq Neuropsiquiatr"},{"key":"2358_CR67","doi-asserted-by":"publisher","first-page":"100538","DOI":"10.1016\/j.ensci.2024.100538","volume":"37","author":"F Riederer","year":"2024","unstructured":"Riederer F, Pirrotta R, Soelch CM, Gantenbein AR, Scutelnic A, Klein A et al (2024) Neurobehavioral features in medication-overuse headache. eNeurologicalSci 37:100538","journal-title":"eNeurologicalSci"},{"key":"2358_CR68","doi-asserted-by":"crossref","unstructured":"Mohseni N, Togha M, Arzaghi SM, Nekooie S, Tafti MF, Fatehi F (2017) Personality traits and anxiety and depressive disorders in patients with medication-overuse headache versus episodic migraine. Prim Care Companion CNS Disord 19(6)","DOI":"10.4088\/PCC.17m02188"},{"key":"2358_CR69","doi-asserted-by":"publisher","first-page":"968111","DOI":"10.3389\/fneur.2022.968111","volume":"13","author":"M Romozzi","year":"2022","unstructured":"Romozzi M, Di Tella S, Rollo E, Quintieri P, Silveri MC, Vollono C et al (2022) Theory of Mind in migraine and medication-overuse headache: A cross-sectional study. Front Neurol 13:968111","journal-title":"Front Neurol"},{"issue":"8","key":"2358_CR70","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/nrneurol.2016.93","volume":"12","author":"A May","year":"2016","unstructured":"May A, Schulte LH (2016) Chronic migraine: risk factors, mechanisms and treatment. Nat Rev Neurol 12(8):455\u2013464","journal-title":"Nat Rev Neurol"},{"issue":"10","key":"2358_CR71","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1080\/15622975.2019.1669822","volume":"21","author":"F Christidi","year":"2020","unstructured":"Christidi F, Karavasilis E, Michels L, Riederer F, Velonakis G, Anagnostou E et al (2020) Dimensions of pain catastrophising and specific structural and functional alterations in patients with chronic pain: Evidence in medication-overuse headache. World J Biol Psychiatry 21(10):726\u2013738","journal-title":"World J Biol Psychiatry"},{"issue":"1","key":"2358_CR72","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s10194-007-0361-3","volume":"8","author":"MF Peres","year":"2007","unstructured":"Peres MF, Mercante JP, Guendler VZ, Corchs F, Bernik MA, Zukerman E et al (2007) Cephalalgiaphobia: a possible specific phobia of illness. J Headache Pain 8(1):56\u201359","journal-title":"J Headache Pain"},{"issue":"1","key":"2358_CR73","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/1129-2377-14-49","volume":"14","author":"G Giannini","year":"2013","unstructured":"Giannini G, Zanigni S, Grimaldi D, Melotti R, Pierangeli G, Cortelli P et al (2013) Cephalalgiaphobia as a feature of high-frequency migraine: a pilot study. J Headache Pain 14(1):49","journal-title":"J Headache Pain"},{"key":"2358_CR74","doi-asserted-by":"crossref","unstructured":"Ablin JN (2024) Nociplastic pain: a critical paradigm for multidisciplinary recognition and management. J Clin Med 13(19)","DOI":"10.3390\/jcm13195741"},{"issue":"1\u20132","key":"2358_CR75","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.drugalcdep.2013.02.034","volume":"132","author":"MO Martel","year":"2013","unstructured":"Martel MO, Wasan AD, Jamison RN, Edwards RR (2013) Catastrophic thinking and increased risk for prescription opioid misuse in patients with chronic pain. Drug Alcohol Depend 132(1\u20132):335\u2013341","journal-title":"Drug Alcohol Depend"},{"issue":"10","key":"2358_CR76","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1111\/pme.12416","volume":"15","author":"MO Martel","year":"2014","unstructured":"Martel MO, Jamison RN, Wasan AD, Edwards RR (2014) The association between catastrophizing and craving in patients with chronic pain prescribed opioid therapy: a preliminary analysis. Pain Med 15(10):1757\u20131764","journal-title":"Pain Med"},{"key":"2358_CR77","doi-asserted-by":"publisher","first-page":"112843","DOI":"10.1016\/j.drugalcdep.2025.112843","volume":"276","author":"JD Ellis","year":"2025","unstructured":"Ellis JD, Chipoletti AE, Tsang S, Nordeck CD, Goodell EMA, Mun CJ et al (2025) Craving for opioid and cannabis use among adults with chronic pain: Insights from a 30-day ecological momentary assessment study. Drug Alcohol Depend 276:112843","journal-title":"Drug Alcohol Depend"},{"key":"2358_CR78","doi-asserted-by":"publisher","first-page":"1307532","DOI":"10.3389\/fpain.2024.1307532","volume":"5","author":"B Valenzuela","year":"2024","unstructured":"Valenzuela B (2024) Landau model for illustrating the learning and unlearning process of nociplastic pain. Front Pain Res (Lausanne) 5:1307532","journal-title":"Front Pain Res (Lausanne)"},{"issue":"1","key":"2358_CR79","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/BF00314210","volume":"236","author":"HC Diener","year":"1989","unstructured":"Diener HC, Dichgans J, Scholz E, Geiselhart S, Gerber WD, Bille A (1989) Analgesic-induced chronic headache: long-term results of withdrawal therapy. J Neurol 236(1):9\u201314","journal-title":"J Neurol"},{"issue":"10","key":"2358_CR80","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1111\/j.1526-4610.1990.hed3010634.x","volume":"30","author":"NT Mathew","year":"1990","unstructured":"Mathew NT, Kurman R, Perez F (1990) Drug induced refractory headache\u2013clinical features and management. Headache 30(10):634\u2013638","journal-title":"Headache"},{"issue":"2","key":"2358_CR81","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/j.1468-2982.2008.01711.x","volume":"29","author":"K Hagen","year":"2009","unstructured":"Hagen K, Albretsen C, Vilming ST, Salvesen R, Gr\u00f8nning M, Helde G et al (2009) Management of medication overuse headache: 1-year randomized multicentre open-label trial. Cephalalgia 29(2):221\u2013232","journal-title":"Cephalalgia"},{"issue":"9","key":"2358_CR82","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1111\/j.1526-4610.2012.02170.x","volume":"52","author":"A Perrotta","year":"2012","unstructured":"Perrotta A, Arce-Leal N, Tassorelli C, Gasperi V, Sances G, Blandini F et al (2012) Acute reduction of anandamide-hydrolase (FAAH) activity is coupled with a reduction of nociceptive pathways facilitation in medication-overuse headache subjects after withdrawal treatment. Headache 52(9):1350\u20131361","journal-title":"Headache"},{"issue":"2","key":"2358_CR83","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1177\/0333102417737779","volume":"38","author":"LN Carlsen","year":"2018","unstructured":"Carlsen LN, Munksgaard SB, Jensen RH, Bendtsen L (2018) Complete detoxification is the most effective treatment of medication-overuse headache: A randomized controlled open-label trial. Cephalalgia 38(2):225\u2013236","journal-title":"Cephalalgia"},{"issue":"6","key":"2358_CR84","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1002\/ejp.1383","volume":"23","author":"IMS Engelstoft","year":"2019","unstructured":"Engelstoft IMS, Carlsen LN, Munksgaard SB, Nielsen M, Jensen RH, Bendtsen L (2019) Complete withdrawal is the most feasible treatment for medication-overuse headache: A randomized controlled open-label trial. Eur J Pain 23(6):1162\u20131170","journal-title":"Eur J Pain"},{"issue":"9","key":"2358_CR85","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1001\/jamaneurol.2020.1179","volume":"77","author":"LN Carlsen","year":"2020","unstructured":"Carlsen LN, Munksgaard SB, Nielsen M, Engelstoft IMS, Westergaard ML, Bendtsen L et al (2020) Comparison of 3 Treatment Strategies for Medication Overuse Headache: A Randomized Clinical Trial. JAMA Neurol 77(9):1069\u20131078","journal-title":"JAMA Neurol"},{"issue":"5","key":"2358_CR86","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1136\/jnnp-2014-308548","volume":"86","author":"ES Kristoffersen","year":"2015","unstructured":"Kristoffersen ES, Straand J, Vetvik KG, Benth J, Russell MB, Lundqvist C (2015) Brief intervention for medication-overuse headache in primary care. The BIMOH study: a double-blind pragmatic cluster randomised parallel controlled trial. J Neurol Neurosurg Psychiatry 86(5):505\u2013512","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"2358_CR87","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1177\/0333102412462638","volume":"33","author":"K Rabe","year":"2013","unstructured":"Rabe K, Pageler L, Gaul C, Lampl C, Kraya T, Foerderreuther S et al (2013) Prednisone for the treatment of withdrawal headache in patients with medication overuse headache: a randomized, double-blind, placebo-controlled study. Cephalalgia 33(3):202\u2013207","journal-title":"Cephalalgia"},{"issue":"8","key":"2358_CR88","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/j.euroneuro.2014.03.010","volume":"24","author":"P Sarchielli","year":"2014","unstructured":"Sarchielli P, Messina P, Cupini LM, Tedeschi G, Di Piero V, Livrea P et al (2014) Sodium valproate in migraine without aura and medication overuse headache: a randomized controlled trial. Eur Neuropsychopharmacol 24(8):1289\u20131297","journal-title":"Eur Neuropsychopharmacol"},{"issue":"1","key":"2358_CR89","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1111\/head.12487","volume":"55","author":"F Taghdiri","year":"2015","unstructured":"Taghdiri F, Togha M, Razeghi Jahromi S, Paknejad SM (2015) Celecoxib vs prednisone for the treatment of withdrawal headache in patients with medication overuse headache: a randomized, double-blind clinical trial. Headache 55(1):128\u2013135","journal-title":"Headache"},{"issue":"9","key":"2358_CR90","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1111\/j.1468-2982.2006.01175.x","volume":"26","author":"P Rossi","year":"2006","unstructured":"Rossi P, Di Lorenzo C, Faroni J, Cesarino F, Nappi G (2006) Advice alone vs. structured detoxification programmes for medication overuse headache: a prospective, randomized, open-label trial in transformed migraine patients with low medical needs. Cephalalgia 26(9):1097\u20131105","journal-title":"Cephalalgia"},{"issue":"14","key":"2358_CR91","doi-asserted-by":"publisher","first-page":"e1409","DOI":"10.1212\/WNL.0000000000200117","volume":"98","author":"TJ Schwedt","year":"2022","unstructured":"Schwedt TJ, Hentz JG, Sahai-Srivastava S, Murinova N, Spare NM, Treppendahl C et al (2022) Patient-Centered Treatment of Chronic Migraine With Medication Overuse: A Prospective, Randomized, Pragmatic Clinical Trial. Neurology 98(14):e1409\u2013e21","journal-title":"Neurology"},{"issue":"9","key":"2358_CR92","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1212\/WNL.57.9.1694","volume":"57","author":"Z Katsarava","year":"2001","unstructured":"Katsarava Z, Fritsche G, Muessig M, Diener HC, Limmroth V (2001) Clinical features of withdrawal headache following overuse of triptans and other headache drugs. Neurology 57(9):1694\u20131698","journal-title":"Neurology"},{"issue":"11","key":"2358_CR93","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1177\/0333102411412088","volume":"31","author":"C Cr\u00e9ac\u2019h","year":"2011","unstructured":"Cr\u00e9ac\u2019h C, Frappe P, Cancade M, Laurent B, Peyron R, Demarquay G et al (2011) In-patient versus out-patient withdrawal programmes for medication overuse headache: a 2-year randomized trial. Cephalalgia 31(11):1189\u20131198","journal-title":"Cephalalgia"},{"issue":"1","key":"2358_CR94","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1129-2377-14-10","volume":"14","author":"P Rossi","year":"2013","unstructured":"Rossi P, Faroni JV, Tassorelli C, Nappi G (2013) Advice alone versus structured detoxification programmes for complicated medication overuse headache (MOH): a prospective, randomized, open-label trial. J Headache Pain 14(1):10","journal-title":"J Headache Pain"},{"issue":"9","key":"2358_CR95","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1177\/0333102414521508","volume":"34","author":"C Tassorelli","year":"2014","unstructured":"Tassorelli C, Jensen R, Allena M, De Icco R, Sances G, Katsarava Z et al (2014) A consensus protocol for the management of medication-overuse headache: Evaluation in a multicentric, multinational study. Cephalalgia 34(9):645\u2013655","journal-title":"Cephalalgia"},{"issue":"1","key":"2358_CR96","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1212\/01.wnl.0000263652.46222.e8","volume":"69","author":"MG B\u00f8e","year":"2007","unstructured":"B\u00f8e MG, Mygland A, Salvesen R (2007) Prednisolone does not reduce withdrawal headache: a randomized, double-blind study. Neurology 69(1):26\u201331","journal-title":"Neurology"},{"issue":"1","key":"2358_CR97","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s10194-023-01630-0","volume":"24","author":"L Grazzi","year":"2023","unstructured":"Grazzi L, D\u2019Amico D, Guastafierro E, Demichelis G, Erbetta A, Fedeli D et al (2023) Efficacy of mindfulness added to treatment as usual in patients with chronic migraine and medication overuse headache: a phase-III single-blind randomized-controlled trial (the MIND-CM study). J Headache Pain 24(1):86","journal-title":"J Headache Pain"},{"issue":"2","key":"2358_CR98","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/j.1468-2982.2007.01488.x","volume":"28","author":"L Pageler","year":"2008","unstructured":"Pageler L, Katsarava Z, Diener HC, Limmroth V (2008) Prednisone vs. placebo in withdrawal therapy following medication overuse headache. Cephalalgia 28(2):152\u2013156","journal-title":"Cephalalgia"},{"issue":"4","key":"2358_CR99","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s10194-011-0339-z","volume":"12","author":"G Sandrini","year":"2011","unstructured":"Sandrini G, Perrotta A, Tassorelli C, Torelli P, Brighina F, Sances G et al (2011) Botulinum toxin type-A in the prophylactic treatment of medication-overuse headache: a multicenter, double-blind, randomized, placebo-controlled, parallel group study. J Headache Pain 12(4):427\u2013433","journal-title":"J Headache Pain"},{"issue":"5","key":"2358_CR100","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1093\/brain\/awz052","volume":"142","author":"JA Pijpers","year":"2019","unstructured":"Pijpers JA, Kies DA, Louter MA, van Zwet EW, Ferrari MD, Terwindt GM (2019) Acute withdrawal and botulinum toxin A in chronic migraine with medication overuse: a double-blind randomized controlled trial. Brain 142(5):1203\u20131214","journal-title":"Brain"},{"issue":"1","key":"2358_CR101","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s10194-017-0763-9","volume":"18","author":"S Cevoli","year":"2017","unstructured":"Cevoli S, Giannini G, Favoni V, Terlizzi R, Sancisi E, Nicodemo M et al (2017) Treatment of withdrawal headache in patients with medication overuse headache: a pilot study. J Headache Pain 18(1):56","journal-title":"J Headache Pain"},{"issue":"6","key":"2358_CR102","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s10194-009-0159-6","volume":"10","author":"P Rossi","year":"2009","unstructured":"Rossi P, Jensen R, Nappi G, Allena M, Consortium C (2009) A narrative review on the management of medication overuse headache: the steep road from experience to evidence. J Headache Pain 10(6):407\u2013417","journal-title":"J Headache Pain"},{"issue":"1","key":"2358_CR103","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s42466-022-00200-0","volume":"4","author":"HC Diener","year":"2022","unstructured":"Diener HC, Kropp P, Dresler T, Evers S, Forderreuther S, Gaul C et al (2022) Management of medication overuse (MO) and medication overuse headache (MOH) S1 guideline. Neurol Res Pract 4(1):37","journal-title":"Neurol Res Pract"},{"issue":"2","key":"2358_CR104","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1046\/j.1468-2982.2000.00028.x","volume":"20","author":"AV Krymchantowski","year":"2000","unstructured":"Krymchantowski AV, Barbosa JS (2000) Prednisone as initial treatment of analgesic-induced daily headache. Cephalalgia 20(2):107\u2013113","journal-title":"Cephalalgia"},{"issue":"11","key":"2358_CR105","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1007\/s10072-017-3098-z","volume":"38","author":"M Paolucci","year":"2017","unstructured":"Paolucci M, Altamura C, Brunelli N, Rizzo AC, Assenza F, Pasqualetti P et al (2017) Methylprednisolone plus diazepam i.v. as bridge therapy for medication overuse headache. Neurol Sci 38(11):2025\u20132029","journal-title":"Neurol Sci"},{"key":"2358_CR106","doi-asserted-by":"publisher","first-page":"1453183","DOI":"10.3389\/fneur.2024.1453183","volume":"15","author":"H Lang","year":"2024","unstructured":"Lang H, Peng C, Wu K, Chen X, Jiang X, He L et al (2024) Efficacy and safety of onabotulinumtoxinA in the treatment of medication overuse headache: a systematic review. Front Neurol 15:1453183","journal-title":"Front Neurol"},{"issue":"10","key":"2358_CR107","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1111\/j.1468-2982.2009.01859.x","volume":"29","author":"HC Diener","year":"2009","unstructured":"Diener HC, Dodick DW, Goadsby PJ, Bigal ME, Bussone G, Silberstein SD et al (2009) Utility of topiramate for the treatment of patients with chronic migraine in the presence or absence of acute medication overuse. Cephalalgia 29(10):1021\u20131027","journal-title":"Cephalalgia"},{"issue":"7","key":"2358_CR108","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1177\/0333102410364676","volume":"30","author":"SK Aurora","year":"2010","unstructured":"Aurora SK, Dodick DW, Turkel CC, DeGryse RE, Silberstein SD, Lipton RB et al (2010) OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial. Cephalalgia 30(7):793\u2013803","journal-title":"Cephalalgia"},{"issue":"7","key":"2358_CR109","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1177\/0333102410364677","volume":"30","author":"HC Diener","year":"2010","unstructured":"Diener HC, Dodick DW, Aurora SK, Turkel CC, DeGryse RE, Lipton RB et al (2010) OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial. Cephalalgia 30(7):804\u2013814","journal-title":"Cephalalgia"},{"issue":"11","key":"2358_CR110","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1001\/jamaneurol.2024.3043","volume":"81","author":"SJ Tepper","year":"2024","unstructured":"Tepper SJ, Dodick DW, Lanteri-Minet M, Dolezil D, Gil-Gouveia R, Lucas C et al (2024) Efficacy and Safety of Erenumab for Nonopioid Medication Overuse Headache in Chronic Migraine: A Phase 4, Randomized, Placebo-Controlled Trial. JAMA Neurol 81(11):1140\u20131149","journal-title":"JAMA Neurol"},{"issue":"7","key":"2358_CR111","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1111\/head.14177","volume":"61","author":"LN Carlsen","year":"2021","unstructured":"Carlsen LN, Rouw C, Westergaard ML, Nielsen M, Munksgaard SB, Bendtsen L et al (2021) Treatment of medication overuse headache: Effect and predictors after 1 year-A randomized controlled trial. Headache 61(7):1112\u20131122","journal-title":"Headache"},{"issue":"1","key":"2358_CR112","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/j.1468-1331.2010.03094.x","volume":"18","author":"RB Grande","year":"2011","unstructured":"Grande RB, Aaseth K, Benth JS, Lundqvist C, Russell MB (2011) Reduction in medication-overuse headache after short information. The Akershus study of chronic headache. Eur J Neurol 18(1):129\u2013137","journal-title":"Eur J Neurol"},{"issue":"4","key":"2358_CR113","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1111\/ane.13475","volume":"144","author":"D D\u2019Amico","year":"2021","unstructured":"D\u2019Amico D, Grazzi L, Guastafierro E, Sansone E, Leonardi M, Raggi A (2021) Withdrawal failure in patients with chronic migraine and medication overuse headache. Acta Neurol Scand 144(4):408\u2013417","journal-title":"Acta Neurol Scand"},{"issue":"2","key":"2358_CR114","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/j.1526-4610.2006.00684.x","volume":"47","author":"SD Silberstein","year":"2007","unstructured":"Silberstein SD, Lipton RB, Dodick DW, Freitag FG, Ramadan N, Mathew N et al (2007) Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial. Headache 47(2):170\u2013180","journal-title":"Headache"},{"issue":"7","key":"2358_CR115","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1111\/j.1468-2982.2007.01326.x","volume":"27","author":"H-C Diener","year":"2007","unstructured":"Diener H-C, Bussone G, Oene JV, Lahaye M, Schwalen S, Goadsby P (2007) Topiramate Reduces Headache Days in Chronic Migraine: A Randomized, Double-Blind, Placebo-Controlled Study. Cephalalgia 27(7):814\u2013823","journal-title":"Cephalalgia"},{"key":"2358_CR116","doi-asserted-by":"crossref","unstructured":"Dodick DW, Turkel CC, DeGryse RE, Aurora SK, Silberstein SD, Lipton RB et al (2010) OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program. Headache 50(6):921\u2009\u2013\u200936","DOI":"10.1111\/j.1526-4610.2010.01678.x"},{"issue":"1","key":"2358_CR117","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jns.2013.05.003","volume":"331","author":"SD Silberstein","year":"2013","unstructured":"Silberstein SD, Blumenfeld AM, Cady RK, Turner IM, Lipton RB, Diener H-C et al (2013) OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients who had acute headache medication overuse at baseline. J Neurol Sci 331(1):48\u201356","journal-title":"J Neurol Sci"},{"key":"2358_CR118","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s10194-016-0591-3","volume":"17","author":"A Negro","year":"2015","unstructured":"Negro A, Curto M, Lionetto L, Martelletti P (2015) A two years open-label prospective study of OnabotulinumtoxinA 195 U in medication overuse headache: a real-world experience. J Headache Pain 17:1","journal-title":"J Headache Pain"},{"issue":"1","key":"2358_CR119","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s42466-022-00200-0","volume":"4","author":"H-C Diener","year":"2022","unstructured":"Diener H-C, Kropp P, Dresler T, Evers S, F\u00f6rderreuther S, Gaul C et al (2022) Management of medication overuse (MO) and medication overuse headache (MOH) S1 guideline. Neurol Res Pract 4(1):37","journal-title":"Neurol Res Pract"},{"issue":"1","key":"2358_CR120","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s10194-020-01173-8","volume":"21","author":"SD Silberstein","year":"2020","unstructured":"Silberstein SD, Cohen JM, Seminerio MJ, Yang R, Ashina S, Katsarava Z (2020) The impact of fremanezumab on medication overuse in patients with chronic migraine: subgroup analysis of the HALO CM study. J Headache Pain 21(1):114","journal-title":"J Headache Pain"},{"issue":"3","key":"2358_CR121","doi-asserted-by":"publisher","first-page":"033310242311521","DOI":"10.1177\/03331024231152169","volume":"43","author":"R Messina","year":"2023","unstructured":"Messina R, Huessler E-M, Puledda F, Haghdoost F, Lebedeva ER, Diener H-C (2023) Safety and tolerability of monoclonal antibodies targeting the CGRP pathway and gepants in migraine prevention: A systematic review and network meta-analysis. Cephalalgia 43(3):03331024231152169","journal-title":"Cephalalgia"},{"issue":"10","key":"2358_CR122","doi-asserted-by":"publisher","first-page":"033310242312061","DOI":"10.1177\/03331024231206162","volume":"43","author":"K Aleksovska","year":"2023","unstructured":"Aleksovska K, Hershey AD, Deen M, de Icco R, Lee MJ, Diener H-C (2023) Efficacy and safety of monoclonal antibodies targeting CGRP in migraine prevention. GRADE tables elaborated by the ad hoc working group of the International Headache Society. Cephalalgia 43(10):03331024231206162","journal-title":"Cephalalgia"},{"issue":"3","key":"2358_CR123","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1097\/WCO.0000000000001061","volume":"35","author":"IA Koumprentziotis","year":"2022","unstructured":"Koumprentziotis IA, Mitsikostas DD (2022) Therapies targeting CGRP signaling for medication overuse headache. Curr Opin Neurol 35(3):353\u2013359","journal-title":"Curr Opin Neurol"},{"issue":"23","key":"2358_CR124","doi-asserted-by":"publisher","first-page":"e33874","DOI":"10.1097\/MD.0000000000033874","volume":"102","author":"C Rhyne","year":"2023","unstructured":"Rhyne C, Cohen JM, Seminerio MJ, Carr K, Krasenbaum LJ (2023) Burden of migraine with acute medication overuse or psychiatric comorbidities and treatment with CGRP pathway-targeted monoclonal antibodies: A review. Med (Baltim) 102(23):e33874","journal-title":"Med (Baltim)"},{"issue":"6","key":"2358_CR125","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1111\/ane.13014","volume":"138","author":"D D\u2019Amico","year":"2018","unstructured":"D\u2019Amico D, Sansone E, Grazzi L, Giovannetti AM, Leonardi M, Schiavolin S et al (2018) Multimorbidity in patients with chronic migraine and medication overuse headache. Acta Neurol Scand 138(6):515\u2013522","journal-title":"Acta Neurol Scand"},{"key":"2358_CR126","doi-asserted-by":"publisher","first-page":"571035","DOI":"10.3389\/fnhum.2020.571035","volume":"14","author":"S Migliore","year":"2020","unstructured":"Migliore S, Paolucci M, Quintiliani L, Altamura C, Maffi S, D\u2019Aurizio G et al (2020) Psychopathological Comorbidities and Clinical Variables in Patients With Medication Overuse Headache. Front Hum Neurosci 14:571035","journal-title":"Front Hum Neurosci"},{"key":"2358_CR127","doi-asserted-by":"crossref","unstructured":"Krymchantowski AV, KAG, Veluttini Pimentel ML, da, Cunha Jevoux C, Michelstaedter Cotrik E (2025) A systematic review and meta-analysis of anti-calcitonin gene-related peptide (CGRP) Monoclonal Antibodies (mAbs) and gepants for episodic or chronic migraine with or without medication overuse headache. SN Compr Clin Med 7:321","DOI":"10.1007\/s42399-025-02059-z"},{"issue":"1","key":"2358_CR128","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s10194-025-02068-2","volume":"26","author":"P Barbanti","year":"2025","unstructured":"Barbanti P, Egeo G, Pistoia F, Aurilia C, Scatena P, Rinalduzzi S et al (2025) GIANT: a prospective, multicenter, real-world study on the effectiveness, safety, and tolerability of atogepant in migraine patients with multiple therapeutic failures. J Headache Pain 26(1):122","journal-title":"J Headache Pain"},{"issue":"4","key":"2358_CR129","doi-asserted-by":"publisher","first-page":"033310242513359","DOI":"10.1177\/03331024251335927","volume":"45","author":"F Vernieri","year":"2025","unstructured":"Vernieri F, Iannone LF, Lo Castro F, Sebastianelli G, De Santis F, Corrado M et al (2025) Effectiveness and tolerability of atogepant in the prevention of migraine: A real life, prospective, multicentric study (the STAR study). Cephalalgia 45(4):03331024251335927","journal-title":"Cephalalgia"},{"issue":"2","key":"2358_CR130","doi-asserted-by":"publisher","first-page":"e209584","DOI":"10.1212\/WNL.0000000000209584","volume":"103","author":"PJ Goadsby","year":"2024","unstructured":"Goadsby PJ, Friedman DI, Holle-Lee D, Demarquay G, Ashina S, Sakai F et al (2024) Efficacy of Atogepant in Chronic Migraine With and Without Acute Medication Overuse in the Randomized, Double-Blind, Phase 3 PROGRESS Trial. Neurology 103(2):e209584","journal-title":"Neurology"},{"issue":"9","key":"2358_CR131","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1056\/NEJMoa2314577","volume":"391","author":"M Ashina","year":"2024","unstructured":"Ashina M, Phul R, Khodaie M, L\u00f6f E, Florea I (2024) A Monoclonal Antibody to PACAP for Migraine Prevention. N Engl J Med 391(9):800\u2013809","journal-title":"N Engl J Med"},{"issue":"1","key":"2358_CR132","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s10194-023-01603-3","volume":"24","author":"L Zhang","year":"2023","unstructured":"Zhang L, Zhou Y, Yang L, Wang Y, Xiao Z (2023) PACAP6-38 improves nitroglycerin-induced central sensitization by modulating synaptic plasticity at the trigeminal nucleus caudalis in a male rat model of chronic migraine. J Headache Pain 24(1):66","journal-title":"J Headache Pain"},{"key":"2358_CR133","doi-asserted-by":"publisher","first-page":"575130","DOI":"10.3389\/fneur.2020.575130","volume":"11","author":"M Sastre Real","year":"2020","unstructured":"Sastre Real M, D\u00edaz de Ter\u00e1n J (2020) OnabotulinumtoxinA Is an Effective Treatment for Chronic Migraine in Patients With Comorbid Fibromyalgia. Front Neurol 11:575130","journal-title":"Front Neurol"},{"issue":"4","key":"2358_CR134","first-page":"330","volume":"55","author":"G Kocaman","year":"2018","unstructured":"Kocaman G, Kahraman N, K\u00f6seo\u011flu BG, Bilgi\u00e7 B, Matur Z, Erta\u015f M et al (2018) Evaluation of OnabotulinumtoxinA Treatment in Patients with Concomitant Chronic Migraine and Temporomandibular Disorders. Noro psikiyatri arsivi 55(4):330\u2013336","journal-title":"Noro psikiyatri arsivi"},{"issue":"1","key":"2358_CR135","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1159\/000528177","volume":"88","author":"GK Lewis","year":"2023","unstructured":"Lewis GK, Carrubba AR, Stanton AP, Craver EC, Li Z, Chen AH (2023) OnabotulinumtoxinA Injections for the Treatment of Myofascial Pelvic Pain: 12-Year Experience at a Tertiary Care Academic Center. Gynecol Obstet Invest 88(1):37\u201346","journal-title":"Gynecol Obstet Invest"},{"issue":"11","key":"2358_CR136","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1016\/j.jsxm.2022.08.188","volume":"19","author":"P Haraldson","year":"2022","unstructured":"Haraldson P, M\u00fchlrad H, Heddini U, Nilsson K, Bohm-Starke N (2022) Botulinum Toxin A for Provoked Vestibulodynia: 12 Months\u2019 Follow-up of a Randomized Controlled Trial. J Sex Med 19(11):1670\u20131679","journal-title":"J Sex Med"},{"issue":"1","key":"2358_CR137","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s10194-025-02034-y","volume":"26","author":"M de Tommaso","year":"2025","unstructured":"de Tommaso M, Scannicchio S, Paparella G, Clemente L, Libro G (2025) Efficacy of monoclonal antibodies against CGRP in migraine patients with fibromyalgia comorbidity: a retrospective monocentric observational study. J Headache Pain 26(1):102","journal-title":"J Headache Pain"},{"issue":"2","key":"2358_CR138","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1037\/0033-295X.84.2.191","volume":"84","author":"A Bandura","year":"1977","unstructured":"Bandura A (1977) Self-efficacy: toward a unifying theory of behavioral change. Psychol Rev 84(2):191\u2013215","journal-title":"Psychol Rev"},{"issue":"2","key":"2358_CR139","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1002\/ejp.1500","volume":"24","author":"LS Mose","year":"2020","unstructured":"Mose LS, Pedersen SS, Jensen RH, Gram B (2020) Medication-overuse headache: The effect of a patient educational programme-A randomized controlled trial. Eur J Pain 24(2):435\u2013447","journal-title":"Eur J Pain"},{"issue":"5","key":"2358_CR140","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1111\/ene.15256","volume":"29","author":"JA Pijpers","year":"2022","unstructured":"Pijpers JA, Kies DA, van Zwet EW, Rosendaal FR, Terwindt GM (2022) Behavioural intervention in medication overuse headache: A concealed double-blind randomized controlled trial. Eur J Neurol 29(5):1496\u20131504","journal-title":"Eur J Neurol"},{"issue":"2","key":"2358_CR141","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1177\/0333102415583146","volume":"36","author":"JA Pijpers","year":"2016","unstructured":"Pijpers JA, Louter MA, de Bruin ME, van Zwet EW, Zitman FG, Ferrari MD et al (2016) Detoxification in medication-overuse headache, a retrospective controlled follow-up study: Does care by a headache nurse lead to cure? Cephalalgia 36(2):122\u2013130","journal-title":"Cephalalgia"},{"issue":"12","key":"2358_CR142","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1177\/0333102416660549","volume":"37","author":"C Tassorelli","year":"2017","unstructured":"Tassorelli C, Jensen R, Allena M, De Icco R, Katsarava Z, Miguel Lainez J et al (2017) The added value of an electronic monitoring and alerting system in the management of medication-overuse headache: A controlled multicentre study. Cephalalgia 37(12):1115\u20131125","journal-title":"Cephalalgia"},{"issue":"5","key":"2358_CR143","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1007\/s13760-021-01758-3","volume":"121","author":"AL Moraes Alves","year":"2021","unstructured":"Moraes Alves AL, Silva IK, Paula Lemos PH, Lomachinsky Torres V, Crevanzi Arraes E, Sampaio Rocha-Filho PA (2021) FRAMES protocol versus simple advice for medication-overuse headache: a prospective, randomized, controlled clinical trial. Acta Neurol Belg 121(5):1259\u20131264","journal-title":"Acta Neurol Belg"},{"issue":"5","key":"2358_CR144","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1136\/jnnp-2014-308548","volume":"86","author":"ES Kristoffersen","year":"2015","unstructured":"Kristoffersen ES, Straand J, Vetvik KG, Benth JS, Russell MB, Lundqvist C (2015) Brief intervention for medication-overuse headache in primary care. The BIMOH study: a double-blind pragmatic cluster randomised parallel controlled trial. J Neurol Neurosurg Psychiatry 86(5):505\u2013512","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"2358_CR145","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s10194-016-0679-9","volume":"17","author":"M Rausa","year":"2016","unstructured":"Rausa M, Palomba D, Cevoli S, Lazzerini L, Sancisi E, Cortelli P et al (2016) Biofeedback in the prophylactic treatment of medication overuse headache: a pilot randomized controlled trial. J Headache Pain 17(1):87","journal-title":"J Headache Pain"},{"issue":"6","key":"2358_CR146","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1046\/j.1526-4610.2002.02123.x","volume":"42","author":"L Grazzi","year":"2002","unstructured":"Grazzi L, Andrasik F, D\u2019Amico D, Leone M, Usai S, Kass SJ et al (2002) Behavioral and pharmacologic treatment of transformed migraine with analgesic overuse: outcome at 3 years. Headache 42(6):483\u2013490","journal-title":"Headache"},{"issue":"1","key":"2358_CR147","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S1352465813000234","volume":"42","author":"S Cathcart","year":"2014","unstructured":"Cathcart S, Galatis N, Immink M, Proeve M, Petkov J (2014) Brief mindfulness-based therapy for chronic tension-type headache: a randomized controlled pilot study. Behav Cogn Psychother 42(1):1\u201315","journal-title":"Behav Cogn Psychother"},{"issue":"12","key":"2358_CR148","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1177\/0333102416667023","volume":"36","author":"F Andrasik","year":"2016","unstructured":"Andrasik F, Grazzi L, D\u2019Amico D, Sansone E, Leonardi M, Raggi A et al (2016) Mindfulness and headache: A new old treatment, with new findings. Cephalalgia 36(12):1192\u20131205","journal-title":"Cephalalgia"},{"issue":"6","key":"2358_CR149","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1111\/head.12362","volume":"54","author":"RE Wells","year":"2014","unstructured":"Wells RE, Smitherman TA, Seng EK, Houle TT, Loder EW (2014) Behavioral and mind\/body interventions in headache: unanswered questions and future research directions. Headache 54(6):1107\u20131113","journal-title":"Headache"},{"issue":"1","key":"2358_CR150","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s10194-017-0728-z","volume":"18","author":"L Grazzi","year":"2017","unstructured":"Grazzi L, Sansone E, Raggi A, D\u2019Amico D, De Giorgio A, Leonardi M et al (2017) Mindfulness and pharmacological prophylaxis after withdrawal from medication overuse in patients with Chronic Migraine: an effectiveness trial with a one-year follow-up. J Headache Pain 18(1):15","journal-title":"J Headache Pain"},{"issue":"1","key":"2358_CR151","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s10194-024-01803-5","volume":"25","author":"D Fedeli","year":"2024","unstructured":"Fedeli D, Ciullo G, Demichelis G, Medina Carrion JP, Bruzzone MG, Ciusani E et al (2024) Longitudinal neurofunctional changes in medication overuse headache patients after mindfulness practice in a randomized controlled trial (the MIND-CM study). J Headache Pain 25(1):97","journal-title":"J Headache Pain"},{"issue":"1","key":"2358_CR152","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.1468-2982.2004.00789.x","volume":"25","author":"Z Katsarava","year":"2005","unstructured":"Katsarava Z, Muessig M, Dzagnidze A, Fritsche G, Diener HC, Limmroth V (2005) Medication overuse headache: rates and predictors for relapse in a 4-year prospective study. Cephalalgia 25(1):12\u201315","journal-title":"Cephalalgia"},{"issue":"6","key":"2358_CR153","doi-asserted-by":"publisher","first-page":"333102425133256","DOI":"10.1177\/03331024251332561","volume":"45","author":"D Fedeli","year":"2025","unstructured":"Fedeli D, Ciullo G, Demichelis G, Medina Carrion JP, Bruzzone MG, Ciusani E et al (2025) Neurotransmitter-related functional connectivity changes in serotonin and dopamine systems after mindfulness in medication overuse headache. Cephalalgia 45(6):3331024251332561","journal-title":"Cephalalgia"},{"key":"2358_CR154","doi-asserted-by":"crossref","unstructured":"Headache Classification Committee of the International Headache Society (IHS) (2018) The International Classification of Headache Disorders, 3rd edition. Cephalalgia 38(1):1\u2013211","DOI":"10.1177\/0333102417738202"},{"issue":"7","key":"2358_CR155","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1111\/ene.14268","volume":"27","author":"HC Diener","year":"2020","unstructured":"Diener HC, Antonaci F, Braschinsky M, Evers S, Jensen R, Lainez M et al (2020) European Academy of Neurology guideline on the management of medication-overuse headache. Eur J Neurol 27(7):1102\u20131116","journal-title":"Eur J Neurol"},{"key":"2358_CR156","doi-asserted-by":"crossref","unstructured":"Schytz HW, Amin FM, Jensen RH, Carlsen L, Maarbjerg S, Lund N et al (2020) Reference programme: diagnosis and treatment of headache disorders and facial pain. Danish Headache Society, 3rd edition, J Headache Pain. 2021;22(1):22","DOI":"10.1186\/s10194-021-01228-4"},{"issue":"7","key":"2358_CR157","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1177\/0333102417736898","volume":"38","author":"LN Carlsen","year":"2018","unstructured":"Carlsen LN, Westergaard ML, Bisgaard M, Schytz JB, Jensen RH (2018) National awareness campaign to prevent medication-overuse headache in Denmark. Cephalalgia 38(7):1316\u20131325","journal-title":"Cephalalgia"},{"issue":"7","key":"2358_CR158","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.neurol.2021.07.003","volume":"177","author":"V Corand","year":"2021","unstructured":"Corand V, working g, Moisset X, Radat F, Lucas C (2021) Medication overuse headache: Updating of the French recommendations regarding the treatment strategies. Rev Neurol (Paris) 177(7):760\u2013764","journal-title":"Rev Neurol (Paris)"},{"issue":"7","key":"2358_CR159","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1111\/ene.13318","volume":"24","author":"ES Kristoffersen","year":"2017","unstructured":"Kristoffersen ES, Straand J, Russell MB, Lundqvist C (2017) Lasting improvement of medication-overuse headache after brief intervention - a long-term follow-up in primary care. Eur J Neurol 24(7):883\u2013891","journal-title":"Eur J Neurol"},{"issue":"7","key":"2358_CR160","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1590\/0004-282x20190078","volume":"77","author":"F Kowacs","year":"2019","unstructured":"Kowacs F, Roesler CAP, Piovesan EJ, Sarmento EM, Campos HC, Maciel JA Jr. et al (2019) Consensus of the Brazilian Headache Society on the treatment of chronic migraine. Arq Neuropsiquiatr 77(7):509\u2013520","journal-title":"Arq Neuropsiquiatr"},{"key":"2358_CR161","doi-asserted-by":"crossref","unstructured":"Nobuo Araki TT, Igarashi H, Shimizu T, Shibata M, Tatsumoto M, Imai N, Kikui S, Iwashita T (2025) Daisuke Danno, on behalf of the study group for headache clinical practiceguideline development. Clinical Practice Guideline for Headache Disorders 2021. Neurol Clin Neurosci","DOI":"10.1111\/ncn3.70042"},{"issue":"11","key":"2358_CR162","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1111\/j.1468-2982.2007.01432.x","volume":"27","author":"J Zidverc-Trajkovic","year":"2007","unstructured":"Zidverc-Trajkovic J, Pekmezovic T, Jovanovic Z, Pavlovic A, Mijajlovic M, Radojicic A et al (2007) Medication overuse headache: clinical features predicting treatment outcome at 1-year follow-up. Cephalalgia 27(11):1219\u20131225","journal-title":"Cephalalgia"},{"issue":"5","key":"2358_CR163","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1111\/ane.12759","volume":"136","author":"ES Kristoffersen","year":"2017","unstructured":"Kristoffersen ES, Straand J, Benth JS, Russell MB, Lundqvist C (2017) Predictors of successful primary care detoxification treatment for medication-overuse headache. Acta Neurol Scand 136(5):486\u2013494","journal-title":"Acta Neurol Scand"},{"issue":"1","key":"2358_CR164","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1177\/0333102418783317","volume":"39","author":"S Bottiroli","year":"2019","unstructured":"Bottiroli S, Allena M, Sances G, De Icco R, Avenali M, Fadic R et al (2019) Psychological, clinical, and therapeutic predictors of the outcome of detoxification in a large clinical population of medication-overuse headache: A six-month follow-up of the COMOESTAS Project. Cephalalgia 39(1):135\u2013147","journal-title":"Cephalalgia"},{"issue":"11","key":"2358_CR165","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1111\/j.1468-2982.2008.01659.x","volume":"28","author":"P Rossi","year":"2008","unstructured":"Rossi P, Faroni JV, Nappi G (2008) Medication overuse headache: predictors and rates of relapse in migraine patients with low medical needs. A 1-year prospective study. Cephalalgia 28(11):1196\u20131200","journal-title":"Cephalalgia"},{"issue":"3","key":"2358_CR166","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1111\/j.1468-2982.2009.01934.x","volume":"30","author":"G Sances","year":"2010","unstructured":"Sances G, Ghiotto N, Galli F, Guaschino E, Rezzani C, Guidetti V et al (2010) Risk factors in medication-overuse headache: a 1-year follow-up study (care II protocol). Cephalalgia 30(3):329\u2013336","journal-title":"Cephalalgia"},{"issue":"6","key":"2358_CR167","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1111\/j.1468-1331.2009.02571.x","volume":"16","author":"MG Boe","year":"2009","unstructured":"Boe MG, Salvesen R, Mygland A (2009) Chronic daily headache with medication overuse: predictors of outcome 1 year after withdrawal therapy. Eur J Neurol 16(6):705\u2013712","journal-title":"Eur J Neurol"},{"issue":"1","key":"2358_CR168","doi-asserted-by":"publisher","first-page":"16013","DOI":"10.1038\/s41598-024-66906-0","volume":"14","author":"SY Oh","year":"2024","unstructured":"Oh SY, Kang JJ, Park HK, Cho SJ, Hong Y, Kang MK et al (2024) Three-month treatment outcome of medication-overuse headache according to classes of overused medications, use of acute medications, and preventive treatments. Sci Rep 14(1):16013","journal-title":"Sci Rep"},{"issue":"10","key":"2358_CR169","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1007\/s00228-014-1726-6","volume":"70","author":"S Cargnin","year":"2014","unstructured":"Cargnin S, Viana M, Sances G, Bianchi M, Ghiotto N, Tassorelli C et al (2014) Combined effect of common gene variants on response to drug withdrawal therapy in medication overuse headache. Eur J Clin Pharmacol 70(10):1195\u20131202","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"2358_CR170","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/head.12979","volume":"57","author":"A Raggi","year":"2017","unstructured":"Raggi A, Giovannetti AM, Leonardi M, Sansone E, Schiavolin S, Curone M et al (2017) Predictors of 12-Months Relapse After Withdrawal Treatment in Hospitalized Patients With Chronic Migraine Associated With Medication Overuse: A Longitudinal Observational Study. Headache 57(1):60\u201370","journal-title":"Headache"},{"issue":"Suppl 1","key":"2358_CR171","doi-asserted-by":"publisher","first-page":"S211","DOI":"10.1007\/s10072-012-1070-5","volume":"33","author":"M Curone","year":"2012","unstructured":"Curone M, D\u2019Amico D, Bussone G (2012) Obsessive-compulsive aspects as predictors of poor response to treatments in patients with chronic migraine and medication overuse. Neurol Sci 33(Suppl 1):S211\u2013S213","journal-title":"Neurol Sci"},{"issue":"7","key":"2358_CR172","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1177\/0333102413477737","volume":"33","author":"G Sances","year":"2013","unstructured":"Sances G, Galli F, Ghiotto N, Allena M, Guaschino E, Frustaci A et al (2013) Factors associated with a negative outcome of medication-overuse headache: a 3-year follow-up (the \u2018CARE\u2019 protocol). Cephalalgia 33(7):431\u2013443","journal-title":"Cephalalgia"},{"issue":"6","key":"2358_CR173","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3109\/09638288.2012.699582","volume":"35","author":"A de Rooij","year":"2013","unstructured":"de Rooij A, Roorda LD, van der Otten RH, Dekker J, Steultjens MP (2013) Predictors of multidisciplinary treatment outcome in fibromyalgia:a systematic review. Disabil Rehabil 35(6):437\u2013449","journal-title":"Disabil Rehabil"},{"issue":"8","key":"2358_CR174","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1097\/j.pain.0000000000002500","volume":"163","author":"B Kundakci","year":"2022","unstructured":"Kundakci B, Kaur J, Goh SL, Hall M, Doherty M, Zhang W et al (2022) Efficacy of nonpharmacological interventions for individual features of fibromyalgia: a systematic review and meta-analysis of randomised controlled trials. Pain 163(8):1432\u20131445","journal-title":"Pain"},{"issue":"1","key":"2358_CR175","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s10194-024-01847-7","volume":"25","author":"I Petrusic","year":"2024","unstructured":"Petrusic I, Ha WS, Labastida-Ramirez A, Messina R, Onan D, Tana C et al (2024) Influence of next-generation artificial intelligence on headache research, diagnosis and treatment: the junior editorial board members\u2019 vision - part 1. J Headache Pain 25(1):151","journal-title":"J Headache Pain"},{"key":"2358_CR176","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1016\/j.csbj.2020.06.006","volume":"18","author":"P Ferroni","year":"2020","unstructured":"Ferroni P, Zanzotto FM, Scarpato N, Spila A, Fofi L, Egeo G et al (2020) Machine learning approach to predict medication overuse in migraine patients. Comput Struct Biotechnol J 18:1487\u20131496","journal-title":"Comput Struct Biotechnol J"}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10194-026-02358-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-026-02358-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-026-02358-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T08:04:38Z","timestamp":1776326678000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s10194-026-02358-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,14]]},"references-count":176,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2358"],"URL":"https:\/\/doi.org\/10.1186\/s10194-026-02358-3","relation":{},"ISSN":["1129-2377"],"issn-type":[{"value":"1129-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,14]]},"assertion":[{"value":"6 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"PM serves as Editor-in-Chief of the Journal of Headache and Pain. The remaining authors hold roles as Junior Editors.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"108"}}